Contact urticaria syndrome with IgE antibody against a cefotiam-unique structure, evoked by nonapparent exposure to cefotiam.
Takahagi S, Tanaka A, Iwamoto K, Ishii K, Hide M.
Clin Exp Dermatol · journal article; case reports · DOI 10.1111/ced.13126Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för cefoperazone. Visa hela publikationsregistret
Takahagi S, Tanaka A, Iwamoto K, Ishii K, Hide M.
Clin Exp Dermatol · journal article; case reports · DOI 10.1111/ced.13126Keçeli SA, Willke A, Tamer GS, Boral OB, Sonmez N, Cağatay P.
APMIS · research support, non-u.s. gov't; journal article · DOI 10.1111/apm.12159Ozen IO, Moralioğlu S, Karabulut R, Bagbanci B, Turkyilmaz Z, Demirogullari B, Sonmez K, Basaklar AC, Kale N.
Acta Chir Belg · journal article; case reports · DOI 10.1080/00015458.2008.11680339Chang YL, Chiou SH, Chou YC, Yen CJ, Tsai TH.
J Pharm Biomed Anal · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jpba.2007.05.002Strom BL, Schinnar R, Gibson GA, Brennan PJ, Berlin JA.
Pharmacoepidemiol Drug Saf · journal article · DOI 10.1002/(sici)1099-1557(199903/04)8:2<81::aid-pds411>3.0.co;2-gShimizu T, Souma S, Nagakura N, Masuzawa T, Iwamoto Y, Yanagihara Y.
Int Arch Allergy Immunol · journal article · DOI 10.1159/000236216